Fierce Pharma

APRIL 23, 2024

Giovanni Caforio, M.D., is lining up a new gig soon after handing all his Bristol Myers Squibb leadership roles in March. | Giovanni Caforio, M.D., is lining up a new gig soon after handing all his Bristol Myers Squibb leadership roles in March. The recent Big Pharma CEO, known for steering the $74 billion acquisition of Celgene, has been proposed as the new chair at Novartis for 2025.

Pharma 346

Pharma 346

MedCity News

APRIL 23, 2024

ImmunityBio therapy Anktiva is now FDA approved for treating patients with non-muscle invasive bladder cancer. The novel immunotherapy works by sparking activity from three types of immune cells. The post FDA Approves Immunotherapy That Can Spare Bladder Cancer Patients From Radical Surgery appeared first on MedCity News.

FDA 123

FDA Patients Biopharma Pharma 123

Fierce Pharma

APRIL 23, 2024

The orphan drug sector has long been clearing growth in the larger pharmaceutical market with booming sales. | The orphan drug sector has long been clearing growth in the larger pharmaceutical market with booming sales. But thanks to blockbuster meds across wider disease areas and other challenges, the lucrative market may soon slow down for the first time in years.

Marketing 290

Marketing Sales Pharmaceutical 290

pharmaphorum

APRIL 23, 2024

After rejecting ImmunityBio’s Anktiva last year, the FDA has now cleared the drug as a treatment for bladder cancer, making it the biotech's first commercial-stage product

FDA 117

FDA 117

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

APRIL 23, 2024

As doctors and patients in the U.S. | As doctors and patients in the U.S. grapple with widening shortages of the popular diabetes therapy Mounjaro and its obesity counterpart Zepbound, the maker of the tirzepatide drugs, Eli Lilly, is forging ahead on its quest to expand capacity for its injectable medicines.

Doctors 261

Doctors Manufacturing Medicine Patients 261

Referral MD

APRIL 23, 2024

ReferralMD, a leader in healthcare technology solutions, is excited to announce the expansion of its Digital Front Door offering using the latest innovation in conversational AI. The Patient Registration & Intake Solution, powered by conversational AI, reimagines how patients engage with healthcare providers. With the healthcare technology market becoming more competitive than ever, ReferralMD differentiates itself with its comprehensive platform, including Digital Front Door, eConsults, R

Patients 104

Patients Electronics CRM Healthcare 104

Pharmaceutical Commerce

APRIL 23, 2024

In an interview with Pharma Commerce Associate Editor Nicholas Saraceno, Will Robinson, Commercial Director, LogiPharma, talks themes of this year's event and future plans for the show.

Pharma 101

Pharma 101

Fierce Pharma

APRIL 23, 2024

Dating to a 2019 clinical hold of a phase 3 trial, getting its gene therapy ra | Dating to a 2019 clinical hold, getting its gene therapy pz-cel across the FDA finish line has been a challenge for troubled Abeona Therapeutics. Now the wait continues as the FDA has rejected the treatment due to CMC issues.

FDA 239

FDA 239

Pharmaceutical Technology

APRIL 23, 2024

The European Commission (EC) has granted marketing authorisation for Pfizer’s EMBLAVEO (aztreonam-avibactam), aimed at treating adults with multidrug-resistant infections where treatment options are limited.

Marketing 101

Marketing 101

Fierce Pharma

APRIL 23, 2024

As the BIOSECURE Act threatens to upend relationships with Chinese contractors and western biopharma companies operating in the U.S., Novartis has elected not to adopt a “wait and see” attitude.

Biopharma 234

Biopharma 234

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

pharmaphorum

APRIL 23, 2024

Novartis has proposed ex-BMS CEO Caforio as the successor to chair Joerg Reinhardt when he steps down next year, as it posts a strong set of Q1 results

109

109

Fierce Pharma

APRIL 23, 2024

Novartis has increased its full-year sales guidance after pulling off a strong first quarter, even though three meds missed analysts’ expectations ahead of their key expansion opportunities. | Novartis has increased its full-year sales guidance after pulling off a strong first quarter, even though three cancer drugs missed analysts’ expectations ahead of their key expansion opportunities.

Sales 201

Sales 201

European Pharmaceutical Review

APRIL 23, 2024

Bristol Myers Squibb (BMS) and Cellares have announced a worldwide capacity reservation and supply agreement for the manufacture of CAR T cell therapies. The deal is valued at up to $380 million in upfront and milestone payments. The agreement will see BMS use Cellares’ fully automated cell therapy manufacturing platform for the clinical and commercial-scale manufacturing of select CAR T cell therapies.

Manufacturing 96

Manufacturing Networking Patients Pharmaceutical 96

Fierce Pharma

APRIL 23, 2024

Following success in cystic fibrosis and sickle cell disease, Vertex’s next big leap is Type 1 diabetes (T1D). | Following success in cystic fibrosis and sickle cell disease, Vertex’s next big leap is Type 1 diabetes. the Boston company develop three pipeline candidates in the indication will be French cell therapy developer and manufacturer TreeFrog Therapeutics.

Manufacturing 195

Manufacturing 195

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

MedCity News

APRIL 23, 2024

It can be tiring pretending to be someone you’re not. For many neurodivergent people at work, this is an everyday reality — and it’s burning them out. The post Neurodivergent Masking: A Hidden Contributor to the $2-Trillion Burnout Crisis appeared first on MedCity News.

99

99

pharmaphorum

APRIL 23, 2024

Pfizer’s Emblaveo has been approved in the EU with a first-in-class indication in multidrug-resistant (MDR) infections. The drug – a combination of beta-lactam antibiotic aztreonam with beta-lactamase inhibitor avibactam – is the first drug of this type to get a green light from the European Commission to treat serious infections caused by MDR Gram-negative bacteria in adults.

90

90

MedCity News

APRIL 23, 2024

No passing fad, AI in healthcare is here, and it’s already improving the lives of patients, healthcare workers, and researchers. How can we make a good thing even better? The post Collaboration Now: Maximizing AI’s Potential in the Industry it Matters Most appeared first on MedCity News.

Healthcare 98

Healthcare Healthcare Patients Ethics 98

pharmaphorum

APRIL 23, 2024

BenevolentAI is embarking on another round of job losses, closing its US office, and shelving its software-as-a-service business to extend its cash reserves into the third quarter of 2025.

80

80

Advertisement

MedCity News

APRIL 23, 2024

Smart but easy tech upgrades can boost margins. The post Don’t Let Inflation Bloat Your Drug Spending appeared first on MedCity News.

101

101

pharmaphorum

APRIL 23, 2024

Phase 3 readout allows Sanofi to prepare US and EU filings for oral BTK inhibitor rilzabrutinib in immune thrombocytopenia (ITP), its first indication

84

84

PharmaVoice

APRIL 23, 2024

Mark Wildgust, vice president of global medical affairs for J&J's oncology division, shares strategies for making clinical trials gender- and trans-inclusive.

Medical 81

Medical 81

PharmaTimes

APRIL 23, 2024

Severe acute malnutrition is responsible for nearly half of all child deaths globally and affects 17 million children annually

Medical 87

Medical 87

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

MedCity News

APRIL 23, 2024

Headspace is going toe-to-toe with the likes of Talkspace and BetterHelp by bringing its mental health services directly to consumers — starting with text-based mental health coaching. The post Why Headspace Is Launching Direct-to-Consumer Services appeared first on MedCity News.

69

69

PharmaTech

APRIL 23, 2024

Regulations for mRNA products are evolving as the market for mRNA expands.

Marketing 98

Marketing 98

PharmaTimes

APRIL 23, 2024

Chronic liver disease and associated cirrhosis account for one million deaths every year

87

87

Integrity Solutions

APRIL 23, 2024

High-performing Sales organizations go beyond hiring for “measurables” and have well thought out plans, processes, coaching and salesperson development strategies in place. The annual NFL Draft is always full of intrigue for many reasons. The real-time drama unfolds as teams select what they consider to be the best 256 college football prospects over a three-day period.

Sales 57

Sales Prospecting Training Product Knowledge 57

Advertisement

Distribution

Pharmaceutical Commerce

APRIL 23, 2024

The latest news for pharma industry insiders.

Pharma 101

Pharma 101

Scott’s Directories

APRIL 23, 2024

Connecting with healthcare professionals in British Columbia (BC) can be a challenging task, especially given the vast and diverse regions of the province. Sales and marketing teams aiming to target physicians, surgeons, and other healthcare providers often face significant obstacles in reaching their prospects effectively. However, leveraging a comprehensive BC physician directory can transform this daunting task into a streamlined and efficient process.

Healthcare 52

Healthcare Healthcare Physicians Doctors 52

Pharmaceutical Commerce

APRIL 23, 2024

In an interview with Pharma Commerce Editor Nicholas Saraceno, Will Robinson, Commercial Director, LogiPharma, discusses the process of keeping the event relevant to the times.

Pharma 52

Pharma 52

Clarify Health

APRIL 23, 2024

Imagine a future where healthcare networks communicate seamlessly, exchanging healthcare data efficiently and effectively. Providers can see every patient’s full health journey, understand all the issues they face, and offer holistic care plans. Payers can streamline their operations, make better decisions faster, and manage risks more effectively. Less manual work and fewer errors pave the way for excellent service delivery — and better member experiences.

Healthcare 52

Healthcare Healthcare Insurance Management 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales